JP Morgan Chase’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-322,400
Closed -$7.69M 5688
2019
Q2
$7.69M Buy
322,400
+265,000
+462% +$5.45M ﹤0.01% 2299
2019
Q1
$744K Sell
57,400
-9,800
-15% -$172K ﹤0.01% 3975
2018
Q4
$1.01M Buy
+67,200
New +$1.74M ﹤0.01% 3744

Other funds holding ADNT

JP Morgan Chase's ADNT Position: Q2 2026 in Review

JP Morgan Chase increased its Adient (ADNT) stake by 73% in Q2 2026, buying an estimated $9.75M and bringing the position to 1,082,233 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2233.

JP Morgan Chase first reported a position in ADNT in Q4 2016 and has held it in 37 quarters since. The position peaked at $46M in Q1 2021. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • JP Morgan Chase held 1,082,233 shares of Adient worth $19.7M as of Q2 2026.
  • JP Morgan Chase bought 456,081 Adient shares in Q2 2026, an estimated $9.75M.
  • Adient made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2233 holding.
  • JP Morgan Chase first reported a position in Adient in Q4 2016 and has held it in 37 quarters since.
  • JP Morgan Chase's Adient position peaked at $46M in Q1 2021.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.